Welcome to our dedicated page for Pitney Bowes SEC filings (Ticker: PBI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Pitney Bowes Inc. filings document the company's operating results, capital structure, governance, and securities disclosures for a public shipping, mailing, and financial-services company. Form 8-K reports include quarterly and annual results, preliminary financial information, Regulation FD disclosures, senior-note financing, debt tender offers, and exhibits such as earnings releases and CEO letters.
Proxy materials cover annual meeting matters, board composition, executive leadership, compensation, and stockholder governance. The filings also identify registered securities including common stock and listed 6.70% Notes due 2043, and describe debt instruments such as 7.250% Senior Notes due 2029, guarantees, indenture supplements, and use-of-proceeds disclosures.
Pitney Bowes has filed a Form 3 (Initial Statement of Beneficial Ownership) announcing the appointment of Brent D. Rosenthal as a Director, effective June 16, 2025. The filing discloses that Rosenthal, whose business address is listed as 3001 Summer Street, Stamford, CT, currently owns no securities of the company.
Key details:
- Filing Type: Form 3 - Initial Statement of Beneficial Ownership
- Position: Director (Non-Employee)
- Beneficial Ownership: No securities beneficially owned
- Filing Date: June 28, 2025
- Document signed by Elisabeth Weinberg as attorney-in-fact on June 18, 2025
This Form 3 filing is a standard regulatory requirement under Section 16(a) of the Securities Exchange Act of 1934, requiring directors, officers, and 10% shareholders to disclose their initial ownership positions upon assuming their roles.
Hestia Capital Management and related entities have filed Amendment No. 10 to their Schedule 13D on Pitney Bowes Inc. (PBI). The filing, dated 16 June 2025, discloses updated ownership levels and a governance development stemming from the January 31, 2024 cooperation agreement between the parties.
Ownership detail
- Hestia Capital Partners LP directly owns 4,810,917 shares (≈2.7% of the 181,253,371 shares outstanding as of 30 April 2025).
- Helios I, LP directly owns 6,639,492 shares (≈3.7%).
- Separately managed accounts (SMAs) advised by Hestia hold 584,636 shares.
- Collectively, Hestia Capital Partners GP, LLC may be deemed to beneficially own 11,450,409 shares (≈6.3%).
- Hestia Capital Management, LLC and Kurtis J. Wolf (CEO of PBI and Hestia’s Managing Partner) report aggregate beneficial ownership of 12,070,325 shares, equating to ≈6.7% of the outstanding common stock.
All shares were purchased in open-market transactions with working capital; cumulative purchase prices total approximately $42.5 million for Hestia Capital and Helios combined, plus about $2.3 million for the SMAs. Mr. Wolf’s personal 35,280 shares were acquired through director compensation arrangements.
Governance update
On 17 June 2025, Pitney Bowes announced that the Board appointed Brent Rosenthal as a director effective 16 June 2025. His appointment is made under Section 1(c) of the January 2024 Cooperation Agreement and he replaces Lance Rosenzweig as a “Replacement Director” for purposes of that agreement.
Key takeaways for investors
- Hestia’s group remains the largest reported active shareholder, controlling nearly 7 % of PBI, reinforcing ongoing activist oversight.
- The Rosenthal appointment signals continued implementation of the cooperation agreement and may influence strategic direction and capital allocation at PBI.